Regulation and Products

Share

In 2009, we won a hard-fought campaign that led to Congress passing a law granting the U.S. Food and Drug Administration (FDA) the authority to regulate all tobacco products, including cigarettes, e-cigarettes, cigars and hookah. Yet, it took the FDA seven years to begin their oversight of many of these products with much more work left to be done. 

Recent spikes in the use of e-cigarettes makes clear that more must be done to regulate tobacco products and the industry's deceptive marketing practices.  We are working to ensure the government fully leverages the regulatory power it now possesses to protect children and adults. 

Tobacco use costs our nation nearly $300 billion in health care and productivity losses each year.

Latest Updates

October 12, 2021
National

The Food and Drug Administration announced this afternoon it has issued marketing orders for the first e-cigarette products authorized by the agency.

September 9, 2021
National

Washington, D.C.— Today the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other tobacco product manufacturers’ applications to keep their harmful products on the market. The September 9th deadline was set as the result of a 2018 lawsuit filed by

July 21, 2021
District Of Columbia

Washington, DC Mayor Bowser has signed legislation that prohibits the sale of some flavored tobacco products. ACS CAN appauds Mayor Bowser and asks a comprehensive approach.

April 29, 2021

WASHINGTON D.C. – The U.S. Food and Drug Administration (FDA) announced today that it will prohibit menthol cigarettes and all flavors in cigars. Ending menthol flavoring in cigarettes and all flavors in cigars is a long overdue step forward in reducing youth tobacco initiation, helping adults quit and reducing tobacco-related

Regulation and Products Resources

In order to effectively reduce tobacco use, it is important to understand the impact of the retail availability of tobacco products. The presence of tobacco retailers can undermine a community’s ability to establish tobacco-free social norms by increasing accessibility to tobacco products including e-cigarettes and increasing exposure to tobacco industry point of sale advertising, marketing and promotions. 

Because JUUL’s products continue to have the largest share of the e-cigarette market, and therefore presumably are undergoing expedited review, we write at this time to express our conclusion that based on all of the publicly available evidence, no JUUL product currently on the market can meet the statutory public health standard. Therefore, they should not receive a marketing order.